Skip to main content

Pleural Effusion, Malignant

0
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Becton Dickinson
Becton DickinsonFRANKLIN LAKES, NJ
2 programs
Chest Drain Insertion and Talc PleurodesisN/A1 trial
PleurX CatheterN/A1 trial
Active Trials
NCT02517749Completed142Est. Mar 2020
NCT04569565Completed12Est. Mar 2019
Rocket Pharmaceuticals
2 programs
Digital Pleural ManometryN/A1 trial
EDIT ManagementN/A1 trial
Active Trials
NCT02805062Unknown65Est. Jul 2017
NCT03319186Unknown30Est. Nov 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Rocket PharmaceuticalsEDIT Management
Rocket PharmaceuticalsDigital Pleural Manometry
Becton DickinsonPleurX Catheter
Becton DickinsonChest Drain Insertion and Talc Pleurodesis

Clinical Trials (4)

Total enrollment: 249 patients across 4 trials

NCT03319186Rocket PharmaceuticalsEDIT Management

EDIT Management Feasibility Trial

Start: Aug 2017Est. completion: Nov 201830 patients
N/AUnknown
NCT02805062Rocket PharmaceuticalsDigital Pleural Manometry

Manometry vs Clinical Assessment in the Detection of Trapped Lung in Patients With Suspected Pleural Malignancy

Start: Jun 2016Est. completion: Jul 201765 patients
N/AUnknown
NCT04569565Becton DickinsonPleurX Catheter

Prospective Evaluation of PleurX Drain for Treatment of Cirrhotic Refractory Ascites

Start: May 2016Est. completion: Mar 201912 patients
N/ACompleted
NCT02517749Becton DickinsonChest Drain Insertion and Talc Pleurodesis

Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural Effusion Vs Usual Inpatient Management

Start: Aug 2015Est. completion: Mar 2020142 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.